Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Magenta Therapeutics, Inc. (MGTA)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/14/2023 |
SC 13G/A
| RA CAPITAL MANAGEMENT, L.P. reports a 0% stake in MAGENTA THERAPEUTICS, INC. |
| 02/14/2023 |
SC 13G/A
| Aquilo Capital Management, LLC reports a 0% stake in Magenta Therapeutics, Inc. |
| 02/14/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2023 |
SC 13G/A
| GILDER GAGNON HOWE & CO LLC reports a 0.7% stake in Magenta Therapeutics, Inc. |
| 09/27/2022 |
SC 13G/A
| RA CAPITAL MANAGEMENT, L.P. reports a 6.1% stake in 1 MAGENTA THERAPEUTICS, INC. |
| 02/14/2022 |
SC 13G/A
| Third Rock Ventures IV, L.P. reports a 11.5% stake in Magenta Therapeutics, Inc. |
| 02/14/2022 |
SC 13G/A
| Deep Track Capital, LP reports a 8.3% stake in Magenta Therapeutics, Inc. |
| 02/14/2022 |
SC 13G/A
| GILDER GAGNON HOWE & CO LLC reports a 6.3% stake in Magenta Therapeutics, Inc. |
| 02/11/2022 |
SC 13G/A
| Casdin Capital, LLC reports a 6.6% stake in Magenta Therapeutics, Inc. |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/11/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2020 |
SC 13G/A
| Atlas Venture Fund X, L.P. reports a 10.6% stake in Magenta Therapeutics, Inc. |
| 02/06/2020 |
SC 13G/A
| Casdin Capital, LLC reports a 7.9% stake in Magenta Therapeutics, Inc. |
| 02/04/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
|
|